Device saturation
Is Moxi Saturated in South Carolina?
Ask Paige tracks 17 practices running Moxi in South Carolina, averaging 5.0★ on Google — about 3.4% of all tracked practices statewide. Compiled from proprietary intelligence gathered by Fathom's collection engine, not manufacturer install figures.
South Carolina runs Moxi at a lower rate than the national average — there's more room to differentiate here than in a typical market.
FDA clearance
510(k) K023541 — Dade Behring, Inc.. Cleared for: Microbiology; Summary.
Treatments paired with Moxi in South Carolina
| Name | Count | Percent | You offer |
|---|---|---|---|
| Dermal Filler | 15 | 88.2% | no |
| Botox / Neurotoxin | 14 | 82.4% | no |
| RF Microneedling | 13 | 76.5% | no |
| Chemical Peel | 11 | 64.7% | no |
| Laser Hair Removal | 10 | 58.8% | no |
| Body Contouring | 8 | 47.1% | no |
| PRP / PRF | 7 | 41.2% | no |
| Vaginal Rejuvenation | 6 | 35.3% | no |
| Porcelain Veneers | 4 | 23.5% | no |
| Laser Resurfacing | 2 | 11.8% | no |
Frequently asked
How many practices in South Carolina have Moxi?
Ask Paige tracks 17 practices running Moxi in South Carolina, about 3.4% of all tracked practices in the state.
Is Moxi saturated in South Carolina?
South Carolina runs Moxi at a lower rate than the national average — there's more room to differentiate here than in a typical market.
Does Moxi have FDA clearance?
FDA 510(k) K023541, cleared for Dade Behring, Inc.. Cleared indications: Microbiology; Summary.
What treatments is Moxi typically used for?
In Ask Paige's corpus, practices running Moxi most often pair it with: Laser Resurfacing.
See if Moxi pencils out for your practice in South Carolina.
See how your practice compares against Ask Paige's proprietary practice intelligence — devices, services, ratings, and demand, side by side with yours.
Start free trial30-day pilot, the Rep-Meeting Test (card required to start; no charge if you cancel within 30 days), then $99/month founding rate for the first 100 practices or $199/month standard rate. Cancel anytime.